Townsend & Associates’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,453
Closed -$2.45M 85
2022
Q1
$2.45M Buy
8,453
+366
+5% +$107K 1.13% 28
2021
Q4
$2.49M Sell
8,087
-16,177
-67% -$5.57M 1.36% 24
2021
Q3
$2.62M Buy
24,264
+15,384
+173% +$5.17M 1.29% 20
2021
Q2
$2.84M Buy
8,880
+159
+2% +$44.6K 1.66% 16
2021
Q1
$2.15M Buy
8,721
+345
+4% +$86.8K 1.4% 23
2020
Q4
$2.28M Buy
8,376
+114
+1% +$28.3K 1.66% 14
2020
Q3
$2.03M Sell
8,262
-324
-4% -$72.8K 1.59% 14
2020
Q2
$1.63M Buy
8,586
+321
+4% +$57.5K 1.37% 31
2020
Q1
$1.35M Buy
+8,265
New +$1.51M 1.4% 38

Other funds holding ISRG

Townsend & Associates's ISRG Position: Q2 2022 in Review

Townsend & Associates sold out of Intuitive Surgical (ISRG) in Q2 2022, closing a stake of 8,453 shares — an estimated $2.45M sold.

Townsend & Associates first reported a position in ISRG in Q1 2020 and held it in 9 quarters. The position peaked at $2.84M in Q2 2021. 1,324 funds tracked by Wall St. Rank hold ISRG as of Q2 2022.

  • Townsend & Associates reported no remaining Intuitive Surgical position as of Q2 2022 after selling out during the quarter.
  • Townsend & Associates sold 8,453 Intuitive Surgical shares in Q2 2022, an estimated $2.45M.
  • Townsend & Associates first reported a position in Intuitive Surgical in Q1 2020 and held it in 9 quarters.
  • Townsend & Associates's Intuitive Surgical position peaked at $2.84M in Q2 2021.
  • 1,324 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2022.

Based on Townsend & Associates's 13F filing for Q2 2022, filed 18 Jul 2022.